GLP-1 Fitness Industry Report
SAN DIEGO, CA — March 12, 2026 —Inspire360, the education technology that powers the world’s top fitness companies and health clubs, today announced the release of its Q1 2026 GLP-1 Club Intelligence Report. This comprehensive analysis maps the dramatic convergence of GLP-1 weight loss medications and the fitness industry, tracking 17 fitness clubs and 10 solution providers that have taken concrete action in the space as of March 2026.
The report reveals that the "fitness-as-medicine" model is going mainstream, with industry leaders ranging from premium clubs offering direct clinical integration to budget chains utilizing telehealth referral models. As the market matures, operators are increasingly navigating a complex regulatory environment, particularly following recent FDA enforcement actions targeting "mass-marketed" compounded GLP-1 alternatives, while positioning themselves for new, government-funded revenue opportunities.
Key Findings from the Q1 2026 Report:
Growing Market Alignment: Approximately 12.4% of U.S. adults have now taken a GLP-1 medication , and ~50% of these users consider a gym membership to support their journey.
The BALANCE Model Opportunity: The Centers for Medicare & Medicaid Services (CMS) has introduced the BALANCE Model, which requires GLP-1 Medicare/Medicaid patients to enroll in lifestyle support programs. This creates a new revenue category for fitness brands that achieve "authorized lifestyle provider" status, with coverage beginning as early as May 2026 for Medicaid.
Deepened Clinical Integration: The industry is shifting toward deeper partnerships, with solution providers like NexGen MD, Dr. B, and others providing the necessary infrastructure for brands such as UFC GYM, F45, and Planet Fitness to deliver clinical weight management services.
The Trainer Readiness Gap: While programs emphasize resistance training to prevent the muscle loss that can account for up to 50% of weight lost during GLP-1 use , the industry currently lacks standardized education for trainers.
"Every program in this report emphasizes the same thing: GLP-1 users need qualified fitness professionals," said Jason Davis, CEO of Inspire360. "To address the 'Trainer Readiness Gap,' Inspire360 is launching a premier specialty certification developed with leading clinical experts. This equips trainers with the critical scope of practice and protocols needed to safely manage the unique needs of members on GLP-1 medications."
By bridging this expertise gap, fitness brands can ensure their staff confidently delivers the resistance training and metabolic guidance essential for preventing muscle loss and driving long-term member results.
For more information on the Q1 2026 GLP-1 Club Intelligence Report, please visit: https://www.inspire360.com/glp-1-report-2026.
-----------------------
About Inspire360
Inspire360 is the education technology that powers the fitness and wellness industry. As the ultimate education solution for health clubs, fitness education organizations, and equipment companies, Inspire360 offers two powerful products: Inspire360 Learn, a full-service LMS that empowers health and fitness companies to deliver online courses, certifications, workshops, and subscriptions, and Inspire360 Club, a transformational training hub that redefines how health clubs deliver staff education.
Built on a 35-year legacy that began with IDEA Health & Fitness Association (1984–2016) and continued through ClubConnect (2012–2019), Inspire360 simplifies the way fitness education is created, managed, and delivered. Today, Inspire360 powers the education ecosystems of leading fitness organizations and health clubs, delivering more courses than any provider in the industry—over 4 million and counting. Learn more at inspire360.com.
